A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage

It is difficult to determine whether an individual therapy contributes to the elongation of survival because of the difficulty of organizing clinical research in patients who receive multiple treatments in HCC. We aimed to establish a new model of survival prediction in patients with intermediate st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninomiya, Masashi, Tsuruoka, Mio, Inoue, Jun, Hiraoka, Atsushi, Iwata, Tomoaki, Sano, Akitoshi, Sato, Kosuke, Onuki, Masazumi, Sawahashi, Satoko, Kuroda, Hidekatsu, Oikawa, Takayoshi, Fujita, Masashi, Abe, Kazumichi, Katsumi, Tomohiro, Sato, Wataru, Igarashi, Go, Iino, Chikara, Endo, Tetsu, Tanabe, Nobukazu, Numao, Hiroshi, Iijima, Katsunori, Matsumoto, Takayuki, Ohira, Hiromasa, Ueno, Yoshiyuki, Masamune, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676419/
https://www.ncbi.nlm.nih.gov/pubmed/38007597
http://dx.doi.org/10.1038/s41598-023-48068-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676419/
https://www.ncbi.nlm.nih.gov/pubmed/38007597
http://dx.doi.org/10.1038/s41598-023-48068-7

Ejemplares similares